Post graduate degree in any branch of Life Sciences, Biochemistry, Biotechnology, Molecular Medicine or allied sciences with strong academic record. The students who have qualified NET, GATE, ICMR-PGI, UGC-CSIR, DBT National eligibility test, or equivalent will be given preference.
M.Pharm, M.VSc with specialization in Pharmacology from a recognized University. OR MSc in Life Sciences, Biotechnology, Molecular Biology from recognized University
Evaluating the health impact of environmental pollutants in population of Sonebhadra district, Uttar Pradesh and laboratory-based three-dimensional lung organoid platform A health assessment study
Demonstrates a robust scientific approach to laboratory analysis. Regularly utilizes personal experience, academic training, and technical insights, including emerging sciences, to address complex technical issues within the laboratory.
Influences and inspires own team and/or brings matrix collaborators together across the organization with eye for progressing teams towards decision points and deepening scientific understanding.
Deciphering the Oncogenic network of Ubiquitin specific peptidase 37 USP37 and its therapeutic potential in prostate cancer. MBBS, BDS, MVSc, M.Pharma, ME, M.Tech degree holders with relevant experience in the cancer research.
Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.
Ph.D, Masters in life sciences from a reputed Institute with 0-2 years relevant experience cell culture, microbiology, molecular biology, zebrafish, mouse handling, mRNA, AAV experience, assay development, high-content imaging.